Annual Shareholders Equity
$51.18 M
-$34.86 M-40.52%
December 31, 2023
Summary
- As of February 8, 2025, LVTX annual stockholders equity is $51.18 million, with the most recent change of -$34.86 million (-40.52%) on December 31, 2023.
- During the last 3 years, LVTX annual shareholders equity has risen by +$43.56 million (+571.54%).
- LVTX annual shareholders equity is now -56.76% below its all-time high of $118.37 million, reached on December 31, 2021.
Performance
LVTX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$32.99 M
-$9.88 M-23.05%
September 30, 2024
Summary
- As of February 8, 2025, LVTX quarterly stockholders equity is $32.99 million, with the most recent change of -$9.88 million (-23.05%) on September 30, 2024.
- Over the past year, LVTX quarterly shareholders equity has dropped by -$21.60 million (-39.57%).
- LVTX quarterly shareholders equity is now -76.01% below its all-time high of $137.55 million, reached on June 30, 2021.
Performance
LVTX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
LVTX Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -40.5% | -39.6% |
| 3 y3 years | +571.5% | -39.6% |
| 5 y5 years | +775.7% | -39.6% |
LVTX Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -56.8% | at low | -72.1% | at low |
| 5 y | 5-year | -56.8% | +775.7% | -76.0% | +332.9% |
| alltime | all time | -56.8% | +775.7% | -76.0% | +332.9% |
LAVA Therapeutics NV Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $32.99 M(-23.1%) |
| Jun 2024 | - | $42.88 M(-15.4%) |
| Mar 2024 | - | $50.66 M(-1.0%) |
| Dec 2023 | $51.18 M(-40.5%) | $51.18 M(-6.3%) |
| Sep 2023 | - | $54.60 M(-14.6%) |
| Jun 2023 | - | $63.89 M(-15.1%) |
| Mar 2023 | - | $75.28 M(-12.5%) |
| Dec 2022 | $86.04 M | $86.04 M(-7.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $92.66 M(-1.5%) |
| Jun 2022 | - | $94.04 M(-13.3%) |
| Mar 2022 | - | $108.41 M(-8.4%) |
| Dec 2021 | $118.37 M(+1453.2%) | $118.37 M(-7.9%) |
| Sep 2021 | - | $128.50 M(-6.6%) |
| Jun 2021 | - | $137.55 M(+3.4%) |
| Mar 2021 | - | $133.02 M(+1645.5%) |
| Dec 2020 | $7.62 M(+30.4%) | $7.62 M |
| Dec 2019 | $5.84 M | - |
FAQ
- What is LAVA Therapeutics NV annual stockholders equity?
- What is the all time high annual shareholders equity for LAVA Therapeutics NV?
- What is LAVA Therapeutics NV annual shareholders equity year-on-year change?
- What is LAVA Therapeutics NV quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for LAVA Therapeutics NV?
- What is LAVA Therapeutics NV quarterly shareholders equity year-on-year change?
What is LAVA Therapeutics NV annual stockholders equity?
The current annual shareholders equity of LVTX is $51.18 M
What is the all time high annual shareholders equity for LAVA Therapeutics NV?
LAVA Therapeutics NV all-time high annual stockholders equity is $118.37 M
What is LAVA Therapeutics NV annual shareholders equity year-on-year change?
Over the past year, LVTX annual stockholders equity has changed by -$34.86 M (-40.52%)
What is LAVA Therapeutics NV quarterly stockholders equity?
The current quarterly shareholders equity of LVTX is $32.99 M
What is the all time high quarterly shareholders equity for LAVA Therapeutics NV?
LAVA Therapeutics NV all-time high quarterly stockholders equity is $137.55 M
What is LAVA Therapeutics NV quarterly shareholders equity year-on-year change?
Over the past year, LVTX quarterly stockholders equity has changed by -$21.60 M (-39.57%)